Patents Examined by Avis Davenport
  • Intranasal calcitonin formulations
    Patent number: 5026825
    Abstract: Disclosed are intranasal formulations comprising calcitonin and .sup..DELTA. -aminolevulinic acid in a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: September 8, 1988
    Date of Patent: June 25, 1991
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.
    Inventors: Peter E. Grebow, Herschel H. Li, Lewis J. Klunk, Jr.